
Loading, please wait...

Loading, please wait...

India has achieved a significant milestone in sickle cell disease screening, reaching over 6.97 crore individuals in tribal belts. This initiative falls under the National Sickle Cell Anaemia Elimination Mission (NSCAEM). Consequently, the government aims to eliminate this genetic condition by 2047. Furthermore, tribal populations receive targeted care through various health facilities across 17 states. These efforts reflect a massive commitment to public health and equity.
The Ministry of Health reported that 3.93 crore genetic status cards have already been distributed to individuals. These screenings target individuals aged 0 to 40 years specifically. Moreover, health workers conduct these tests at district hospitals and Ayushman Arogya Mandirs. Therefore, the diagnostic reach spans across diverse tribal-dominated regions. This systematic approach ensures early detection and better management of the disease.
The government has approved 17 Centers of Excellence across 15 states to handle complex cases. These centers provide specialized care and technical guidance to local health providers. Additionally, primary health centers offer folic acid supplementation and nutritional support. Consequently, patients receive better lifestyle counseling and pre-marital guidance to manage the disease effectively. These interventions aim to improve the quality of life for affected individuals significantly.
Q1: What is the age group targeted for SCD screening in India?
The National Sickle Cell Anaemia Elimination Mission targets individuals between 0 and 40 years of age for comprehensive screening and diagnosis.
Q2: What services are provided to patients diagnosed with SCD?
Patients receive regular follow-ups, lifestyle counseling, nutritional support like folic acid, and referral services to higher medical facilities when needed.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional judgment. Refer to the latest local and national guidelines for clinical practice.
References

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


India's NSCAEM has conducted 6.97 crore SCD screenings and distributed 3.93 crore genetic cards to tribal areas to eliminate sickle cell anemia by 2047....
5 months ago

A new case study illuminates how functional connectivity changes drive recovery from pure alexia following posterior cerebral artery infarction. Functional reorganization supports reading recovery despite permanent structural tract disconnection, highlighting key implications for stroke rehabilitation.
Today

A premature neonate developed upper limb compartment syndrome after uterine rupture extruded the arm through a scar defect. Conservative management with continuous monitoring yielded complete functional recovery and normal limb growth at 10-year follow-up, highlighting non-operative safety in selected cases.
Today

Dendritic cells bridge innate and adaptive immunity in myocardial infarction. This review explores their pathological roles, circulating dynamics, novel tolerogenic interventions, and how standard cardiovascular medications modulate dendritic cells to improve post-infarction myocardial repair and patient outcomes.
Today

Endoscopic posterior cervical fusion combines minimally invasive decompression, joint preparation, and rigid screw-rod fixation for atlantoaxial pathologies. Early clinical findings demonstrate solid bony union, excellent symptom relief, and minimal soft-tissue morbidity without significant vascular compromise.
Yesterday

Atherosclerosis involves extensive glycometabolic reprogramming across immune and vascular cells. This review examines how glycolysis, the pentose phosphate pathway, and lactate-driven epigenetic shifts fuel plaque vulnerability, while highlighting novel therapeutic targets like PFKFB3 and LDHA.
Today